GABAA receptor inhibitors, particularly those classified as Rp inhibitors, act by modulating the activity of the GABAA receptor, a key component of the central nervous system. The GABAA receptor is a type of ionotropic receptor that mediates the inhibitory effects of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the brain. GABAA receptors are chloride ion channels, and when activated by GABA, they allow chloride ions to enter the neuron, leading to hyperpolarization and a reduction in neuronal excitability. GABAA Rp inhibitors interfere with this process by binding to specific sites on the receptor and inhibiting its function, thereby preventing the flow of chloride ions into the cell. This modulation can alter the balance between excitatory and inhibitory signals in the nervous system.
These inhibitors are highly selective for certain GABAA receptor subtypes, as the receptor itself is a pentameric complex composed of various subunits. Depending on the combination of subunits (α, β, γ, δ, ε, etc.), the receptor can have different pharmacological properties and be differentially expressed in various regions of the brain. The structural diversity of GABAA receptors provides a broad spectrum of sites for the binding of Rp inhibitors, allowing for nuanced control of receptor activity. The specificity and mode of inhibition depend on the molecular configuration of the inhibitor and the subunit composition of the receptor, making GABAA Rp inhibitors important tools for studying the physiology of GABAergic signaling pathways and the functional role of distinct GABAA receptor subtypes in neural circuits.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $80.00 $275.00 | ||
Bicuculline competitively inhibits GABAA Rp by binding to the GABA binding site on the receptor, preventing GABA itself from binding and thus inhibiting the receptor's ion channel function. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $66.00 $280.00 $1300.00 | 11 | |
Picrotoxin non-competitively inhibits GABAA Rp by binding to the receptor's chloride channel pore, preventing chloride ion flow and inhibiting receptor activity. | ||||||
Gabazine | 105538-73-6 | sc-211552 | 10 mg | $714.00 | 3 | |
Gabazine acts as a competitive antagonist at GABAA Rp by blocking GABA's binding, which inhibits the receptor's function. | ||||||
Penicillin G sodium salt | 69-57-8 | sc-257971 sc-257971A sc-257971B sc-257971C sc-257971D | 1 mg 10 mg 1 g 5 g 100 g | $25.00 $36.00 $46.00 $168.00 $260.00 | 1 | |
Penicillin G non-selectively inhibits GABAA Rp by binding to the receptor and preventing chloride channel opening, which inhibits the receptor's function. | ||||||
Flumazenil (Ro 15-1788) | 78755-81-4 | sc-200161 sc-200161A | 25 mg 100 mg | $108.00 $363.00 | 10 | |
Flumazenil is a competitive antagonist at the benzodiazepine site on GABAA Rp, which inhibits the receptor by preventing the positive allosteric modulation by benzodiazepines. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $40.00 | ||
Furosemide inhibits GABAA Rp by blocking the associated chloride channels, particularly those containing α6 and δ subunits, leading to inhibition of receptor activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Zinc ions can non-competitively inhibit GABAA Rp by binding to specific sites on the receptor, which leads to reduced chloride ion channel function. | ||||||